Acquired itraconazole resistance in Aspergillus fumigatus

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 3, 2001, Pages 333-340

  Dannaoui, E ^a   Borel, E ^a   Monier, M F ^a   Piens, M A ^a   Picot, S ^a   Persat, F ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; FUNGAL DNA; ITRACONAZOLE; PRIMER DNA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BRAIN; CASE REPORT; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; FEMALE; HUMAN; IN VIVO STUDY; KIDNEY; LUNG MYCOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; NONHUMAN; ORGAN CULTURE; RANDOM AMPLIFIED POLYMORPHIC DNA; SURVIVAL;

EID: 0035096293     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.3.333     Document Type: Article

References (26)

1. Invasive aspergillosis
2. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome. EORTC invasive fungal infections cooperative group
3. Human mycoses: Drugs and targets for emerging pathogens
4. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole
5. Antifungal agents. Part II. The azoles
6. Azole drug resistance in yeasts
7. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole
8. Itraconazole resistance in Aspergillus fumigatus
9. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus
10. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
11. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
12. Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation
13. Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole
14. Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA
15. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus
16. Resistance of Aspergillus fumigatus to itraconazole
17. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings
18. Use of DNA moderately repetitive sequence to type Aspergillus fumigatus isolates from aspergilloma patients
19. DNA fingerprinting of Aspergillus fumigatus isolates from patients with aspergilloma
20. Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis
21. The ins and outs of DNA fingerprinting the infectious fungi
22. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
23. Induced expression of a novel ABC transporter gene adr1 from Aspergillus fumigatus in response to itraconazole
24. Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent
25. Molecular typing by random amplification of polymorphic DNA and M13 southern hybridization of related paired isolates of Aspergillus fumigatus